Lastly, our data indicate that VEGFA, TGFB1, and CSF1 are candidate biomarkers for a tesamorelin response among PLWH with NAFLD, which should be explored in future studies. This evidence concerns the gene VEGFA and metabolic dysfunction-associated steatotic liver disease.